Literature DB >> 14594782

Structural differences between rye and wheat breads but not total fiber content may explain the lower postprandial insulin response to rye bread.

Katri S Juntunen1, David E Laaksonen, Karin Autio, Leo K Niskanen, Jens J Holst, Kari E Savolainen, Kirsi-Helena Liukkonen, Kaisa S Poutanen, Hannu M Mykkänen.   

Abstract

BACKGROUND: Rye bread has a beneficial effect on the postprandial insulin response in healthy subjects. The role of rye fiber in insulin and glucose metabolism is not known.
OBJECTIVE: The aim of the study was to determine the effect of the content of rye fiber in rye breads on postprandial insulin and glucose responses.
DESIGN: Nineteen healthy postmenopausal women aged 61 +/- 1 y, with a body mass index (in kg/m(2)) of 26.0 +/- 0.6, and with normal glucose tolerance participated in the study. The test products were refined wheat bread (control), endosperm rye bread, traditional rye bread, and high-fiber rye bread; each bread provided 50 g available carbohydrate and was served with breakfast. Plasma glucose, insulin, glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and serum C-peptide were measured in fasting and 8 postprandial blood samples. In vitro starch hydrolysis and the microscopic structure of the breads were also determined.
RESULTS: Postprandial insulin, glucose-dependent insulinotropic polypeptide, and C-peptide responses to the rye breads were significantly lower than the response to the control; no significant differences in insulin and C-peptide responses to the rye breads were found. Glucose and glucagon-like peptide 1 responses to the rye breads were not significantly different from those to the control, except at 150 and 180 min. In vitro starch hydrolysis was slower in all rye breads than in the control, and the structure of continuous matrix and starch granules differed between the rye and control breads.
CONCLUSION: Total fiber content does not explain the lower postprandial insulin response to rye bread than to wheat bread, but structural differences between rye and wheat breads might.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14594782     DOI: 10.1093/ajcn/78.5.957

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  31 in total

Review 1.  Effects of whole grains on coronary heart disease risk.

Authors:  Kristina A Harris; Penny M Kris-Etherton
Journal:  Curr Atheroscler Rep       Date:  2010-11       Impact factor: 5.113

Review 2.  Whole grain and refined grain consumption and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies.

Authors:  Dagfinn Aune; Teresa Norat; Pål Romundstad; Lars J Vatten
Journal:  Eur J Epidemiol       Date:  2013-10-25       Impact factor: 8.082

3.  Postprandial effects of test meals including concentrated arabinoxylan and whole grain rye in subjects with the metabolic syndrome: a randomised study.

Authors:  M L Hartvigsen; H N Lærke; A Overgaard; J J Holst; K E Bach Knudsen; K Hermansen
Journal:  Eur J Clin Nutr       Date:  2014-03-05       Impact factor: 4.016

4.  Effects of concentrated arabinoxylan and β-glucan compared with refined wheat and whole grain rye on glucose and appetite in subjects with the metabolic syndrome: a randomized study.

Authors:  M L Hartvigsen; S Gregersen; H N Lærke; J J Holst; K E Bach Knudsen; K Hermansen
Journal:  Eur J Clin Nutr       Date:  2013-11-20       Impact factor: 4.016

5.  A diet high in fatty fish, bilberries and wholegrain products improves markers of endothelial function and inflammation in individuals with impaired glucose metabolism in a randomised controlled trial: the Sysdimet study.

Authors:  V D F de Mello; U Schwab; M Kolehmainen; W Koenig; M Siloaho; K Poutanen; H Mykkänen; M Uusitupa
Journal:  Diabetologia       Date:  2011-08-26       Impact factor: 10.122

6.  Intake of whole grains and incidence of oesophageal cancer in the HELGA Cohort.

Authors:  Guri Skeie; Tonje Braaten; Anja Olsen; Cecilie Kyrø; Anne Tjønneland; Rikard Landberg; Lena Maria Nilsson; Maria Wennberg; Kim Overvad; Lene Angell Åsli; Elisabete Weiderpass; Eiliv Lund
Journal:  Eur J Epidemiol       Date:  2015-06-20       Impact factor: 8.082

7.  Plasma alkylresorcinols C17:0/C21:0 ratio, a biomarker of relative whole-grain rye intake, is associated to insulin sensitivity: a randomized study.

Authors:  O K Magnusdottir; R Landberg; I Gunnarsdottir; L Cloetens; B Akesson; M Landin-Olsson; F Rosqvist; D Iggman; U Schwab; K-H Herzig; M J Savolainen; L Brader; K Hermansen; M Kolehmainen; K Poutanen; M Uusitupa; I Thorsdottir; U Risérus
Journal:  Eur J Clin Nutr       Date:  2014-02-19       Impact factor: 4.016

8.  Effect of commercial rye whole-meal bread on postprandial blood glucose and gastric emptying in healthy subjects.

Authors:  Joanna Hlebowicz; Jenny Maria Jönsson; Sandra Lindstedt; Ola Björgell; Gassan Darwich; Lars-Olof Almér
Journal:  Nutr J       Date:  2009-06-16       Impact factor: 3.271

9.  Effect of rye bread breakfasts on subjective hunger and satiety: a randomized controlled trial.

Authors:  Hanna Isaksson; Helena Fredriksson; Roger Andersson; Johan Olsson; Per Aman
Journal:  Nutr J       Date:  2009-08-26       Impact factor: 3.271

10.  Endosperm and whole grain rye breads are characterized by low post-prandial insulin response and a beneficial blood glucose profile.

Authors:  Liza A H Rosén; Lorena O Blanco Silva; Ulrika K Andersson; Cecilia Holm; Elin M Ostman; Inger M E Björck
Journal:  Nutr J       Date:  2009-09-25       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.